BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 20072886)

  • 1. A "dock and lock" approach to preparation of targeted liposomes.
    Backer MV; Backer JM
    Methods Mol Biol; 2010; 605():257-66. PubMed ID: 20072886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A "Dock and Lock" Approach to Preparation of Targeted Liposomes.
    Backer MV; Backer JM
    Methods Mol Biol; 2017; 1522():83-92. PubMed ID: 27837532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembled "dock and lock" system for linking payloads to targeting proteins.
    Backer MV; Patel V; Jehning BT; Backer JM
    Bioconjug Chem; 2006; 17(4):912-9. PubMed ID: 16848397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine-containing fusion tag for site-specific conjugation of therapeutic and imaging agents to targeting proteins.
    Backer MV; Levashova Z; Levenson R; Blankenberg FG; Backer JM
    Methods Mol Biol; 2008; 494():275-94. PubMed ID: 18726580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adapter protein for site-specific conjugation of payloads for targeted drug delivery.
    Backer MV; Gaynutdinov TI; Patel V; Jehning BT; Myshkin E; Backer JM
    Bioconjug Chem; 2004; 15(5):1021-9. PubMed ID: 15366955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Disulfide Bond Cys255-Cys279 in the Immunoglobulin-Like Domain of Anthrax Toxin Receptor 2 Is Required for Membrane Insertion of Anthrax Protective Antigen Pore.
    Jacquez P; Avila G; Boone K; Altiyev A; Puschhof J; Sauter R; Arigi E; Ruiz B; Peng X; Almeida I; Sherman M; Xiao C; Sun J
    PLoS One; 2015; 10(6):e0130832. PubMed ID: 26107617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface immobilization of active vascular endothelial growth factor via a cysteine-containing tag.
    Backer MV; Patel V; Jehning BT; Claffey KP; Backer JM
    Biomaterials; 2006 Nov; 27(31):5452-8. PubMed ID: 16843524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The longer isoform and Cys-1 disulfide bridge of rat surfactant protein A are not essential for phospholipid and type II cell interactions.
    Zhang M; Damodarasamy M; Elhalwagi BM; McCormack FX
    Biochemistry; 1998 Nov; 37(47):16481-8. PubMed ID: 9843414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF.
    Keck RG; Berleau L; Harris R; Keyt BA
    Arch Biochem Biophys; 1997 Aug; 344(1):103-13. PubMed ID: 9244387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly of targeting complexes driven by a single-chain antibody.
    Backer MV; Elliot J; Gaynutdinov TI; Backer JM
    J Immunol Methods; 2004 Jun; 289(1-2):37-45. PubMed ID: 15251410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disulfide bonding arrangements in active forms of the somatomedin B domain of human vitronectin.
    Kamikubo Y; De Guzman R; Kroon G; Curriden S; Neels JG; Churchill MJ; Dawson P; Ołdziej S; Jagielska A; Scheraga HA; Loskutoff DJ; Dyson HJ
    Biochemistry; 2004 Jun; 43(21):6519-34. PubMed ID: 15157085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric ribonuclease as a source of human adapter protein for targeted drug delivery.
    Gaynutdinov TI; Myshkin E; Backer JM; Backer MV
    Protein Eng; 2003 Oct; 16(10):771-5. PubMed ID: 14600207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photo-cross-linking of rabbit skeletal troponin I deletion mutants with troponin C and its thiol mutants: the inhibitory region enhances binding of troponin I fragments to troponin C.
    Jha PK; Mao C; Sarkar S
    Biochemistry; 1996 Aug; 35(34):11026-35. PubMed ID: 8780504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insertion and orientation of a synthetic peptide representing the C-terminus of the A1 domain of Shiga toxin into phospholipid membranes.
    Saleh MT; Ferguson J; Boggs JM; Gariépy J
    Biochemistry; 1996 Jul; 35(29):9325-34. PubMed ID: 8755710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of membrane translocation by anthrax protective antigen.
    Wesche J; Elliott JL; Falnes PO; Olsnes S; Collier RJ
    Biochemistry; 1998 Nov; 37(45):15737-46. PubMed ID: 9843379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the disulfide bonds and free cysteine residues of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.
    Yen TY; Pal S; de la Maza LM
    Biochemistry; 2005 Apr; 44(16):6250-6. PubMed ID: 15835913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semisynthesis of cytotoxic proteins using a modified protein splicing element.
    Evans TC; Benner J; Xu MQ
    Protein Sci; 1998 Nov; 7(11):2256-64. PubMed ID: 9827992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of Bacillus thuringiensis cytolytic toxins in association with a phospholipid bilayer.
    Du J; Knowles BH; Li J; Ellar DJ
    Biochem J; 1999 Feb; 338 ( Pt 1)(Pt 1):185-93. PubMed ID: 9931315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered covalent leucotoxin heterodimers form functional pores: insights into S-F interactions.
    Joubert O; Viero G; Keller D; Martinez E; Colin DA; Monteil H; Mourey L; Dalla Serra M; Prévost G
    Biochem J; 2006 Jun; 396(2):381-9. PubMed ID: 16494579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of an analog of the major rate-determining disulfide folding intermediate of bovine pancreatic ribonuclease A.
    Laity JH; Lester CC; Shimotakahara S; Zimmerman DE; Montelione GT; Scheraga HA
    Biochemistry; 1997 Oct; 36(42):12683-99. PubMed ID: 9335525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.